IP Library Granted Patent US 11,974,767
Granted Patent B2
US 11,974,767 · App. 17/154,232 · Granted May 7, 2024

Cellulite treatment system

Inventors: Joshua Makower (Los Altos Hills, CA); Jonathan Podmore (San Carlos, CA); Earl Bright, II (Sunnyvale, CA); John Hanley (Manhattan Beach, CA); Pablo Acosta (Newark, CA); Theodore Ketai (Chico, CA); William Sauway Law (Palo Alto, CA); Michael Schaller (Louisville, CO); Bryan Hartley (Redwood City, CA)
Assignee: Revelle Aesthetics, Inc.
A61B17/320016A61B1/06A61B2017/00747A61B2017/00792
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,974,767
App. No.
17/154,232
Granted
May 7, 2024
Kind
B2
Abstract

Systems and methods for treating cellulite including an apparatus that applies or a method involving separating septa to eliminate or reduce the appearance of cellulite. In one approach, an interventional tool is placed between tissue layers to engage and treat septa connecting tissue layers between which fat deposits are contained.

Claims (16)

1. A cellulite treatment system for treating expressions of cellulite on a patient's skin associated with a septa treatment site, comprising:

a handle; and

an elongate member insertable through the skin capable of expanding at least one region from a smaller state to a wider state and engaging one or more regions of septa subcutaneously, wherein the wider state is configurable to both define a septa hooking structure as well as a septa cutting or slicing structure, wherein when presenting the septa hooking structure the septa cutting or slicing structure is covered and a first link of the septa hooking structure is connected to a second link of the septa hooking structure at a pivot laterally displaced from the elongate member.

2. The system claim 1 , wherein in the wider state when configured to present the septa cutting or slicing structure an at least one cutting surface is exposed.

3. The system claim 2 , wherein the at least one cutting surface is sharp.

4. The system claim 2 , wherein the at least one cutting surface is blunt but capable of delivering energy to tissue sufficient to cut.

5. The system claim 1 , wherein the wider state is capable of tugging tissue to produce an effect of at least a portion of cellulite expressed on a surface of skin prior to treatment.

6. The system claim 1 , further comprising a light associated with the elongate member, the light being capable of being viewed through a surface of skin.

7. The system claim 1 , wherein the treatment system is capable of providing tactile feedback signaling that a treatment device is placed in a cutting position.

8. The system claim 1 , wherein the treatment system includes an electrical switch to control a light providing transillumination.

9. The system claim 1 , wherein a constant force spring provides control of treatment device deployment.

10. The system claim 1 , further comprising lasso structure for treating tissue.

11. The system claim 1 , further comprising one or more strain gauges configured to facilitate identifying target septa as well as the progression and completion of a cellulite treatment procedure.

12. The system claim 1 , further comprising a light source configured along the treatment system, the light source configured to be operated from a proximal end of the treatment system.

13. The system claim 1 , further comprising a light source that is configured to change color depending on a configuration of the system such that the light source is a first color when the treatment system is configured prior to deployment or treatment and a second color when the treatment system is deployed or after treatment.

14. The system of claim 1 , further comprising a light source configured to generate a projection having a pre-determined size on the surface of the skin that is associated with a desired distance below the skin.

Assignments (2)
SECURITY INTEREST Recorded May 31, 2023
From: REVELLE AESTHETICS, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 063803/0159 →
CHANGE OF NAME Recorded Jul 19, 2021
From: NC8, INC.
To: REVELLE AESTHETICS, INC
Reel/Frame 056907/0642 →
Continuity (7)
Continuation In Part PCTUS2019042871 · Jul 22, 2019
Provisional Application 62702314 · Jul 23, 2018
Provisional Application 62736016 · Sep 25, 2018
Provisional Application 62798515 · Jan 30, 2019
Provisional Application 62802368 · Feb 7, 2019
Provisional Application 62825447 · Mar 28, 2019
Related Publication 20210137551A1 · May 13, 2021
Cited By (4)
US 12,527,594 US 12,527,597 US 12,588,923 US 12,702,473